Hampel, H. et al. Full Genomic Analysis of Anavex®2-73 Phase 2a Alzheimer’s Disease Study Identifies Biomarkers Enabling Targeted Therapy and a Precision Medicine Approach. in Alzheimer’s Association International Conference (AAIC) 2018 vol. 14 P1519–P1520 (2018).
Hampel, H. et al. Systematic Processing of Full Genomic Analysis of the Anavex®2-73 Phase 2a Alzheimer’s Disease Study Identifies Biomarkers Enabling a Precision Medicine Approach. in Alzheimer’s Association International Conference (AAIC) 2018 vol. 14 P1666–P1667 (John Wiley & Sons, Ltd, 2018).